Injectable HIV ART Is an Effective Alternative to Oral Medications
- On February 21, 2024, the NIH issued a press announcement revealing that long-acting injectable antiretroviral therapy (ART) using cabotegravir and rilpivirine was more effective than oral ART at suppressing human immunodeficiency virus (HIV) replication in patients who could not achieve or maintain viral suppression with oral...